4//SEC Filing
Wade M. Andrew 4
Accession 0001209191-20-003571
CIK 0001323885other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 7:55 AM ET
Size
8.9 KB
Accession
0001209191-20-003571
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Wade M. Andrew
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2020-01-14$6.27/sh+10,000$62,700→ 155,120 total - Sale
Common Stock
2020-01-14$34.00/sh−10,000$340,000→ 145,120 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-01-14−10,000→ 25,000 totalExercise: $6.27From: 2013-10-25Exp: 2022-10-25→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]These shares were exercised pursuant to a 10b5-1 trading plan.
- [F2]These shares were sold pursuant to a 10b5-1 trading plan.
- [F3]These options were granted on October 25, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001560591
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 7:55 AM ET
- Size
- 8.9 KB